|
Volumn 425, Issue 2, 2004, Pages 200-206
|
Chemical modification of muscle protein in diabetes
|
Author keywords
Advanced glycation end product; Advanced lipoxidation end product; Chemical modification; Collagen; Diabetes; Fructose lysine; Glycation; Maillard reaction; Muscle protein; Myofibril; Protein
|
Indexed keywords
6 N CARBOXYMETHYLLYSINE;
ADVANCED GLYCATION END PRODUCT;
CARBOCISTEINE;
COLLAGEN;
FRUCTOSE;
LYSINE;
LYSINE DERIVATIVE;
MUSCLE PROTEIN;
N EPSILON CARBOXYETHYLLYSINE;
THIOL DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DIABETES MELLITUS;
GASTROCNEMIUS MUSCLE;
GLYCATION;
MEASUREMENT;
MUSCLE FIBRIL;
MUSCLE LEVEL;
NONHUMAN;
OXIDATION;
PRIORITY JOURNAL;
PROTEIN MODIFICATION;
RAT;
RAT STRAIN;
SKELETAL MUSCLE;
SKIN;
SOLUBILITY;
ANIMALS;
COLLAGEN;
DIABETES MELLITUS, EXPERIMENTAL;
GLYCOSYLATION END PRODUCTS, ADVANCED;
LIPID PEROXIDATION;
LYSINE;
MUSCLE PROTEINS;
MUSCLE, SKELETAL;
RATS;
RATS, SPRAGUE-DAWLEY;
SKIN;
STREPTOZOCIN;
|
EID: 2142773120
PISSN: 00039861
EISSN: None
Source Type: Journal
DOI: 10.1016/j.abb.2004.03.012 Document Type: Article |
Times cited : (59)
|
References (24)
|